MedPath

Creso Pharma Ltd

🇨🇦Canada
Ownership
-
Employees
6
Market Cap
-
Website
Introduction

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

CANADA:13

Drug Approvals

BRINAVESS

Approval Date
Jan 23, 2018
CANADA

ACTIKERALL

Approval Date
Feb 19, 2016
CANADA

EPURIS

Approval Date
May 7, 2013
CANADA

EPURIS

Approval Date
May 7, 2013
CANADA

EPURIS

Approval Date
May 7, 2013
CANADA

EPURIS

Approval Date
May 7, 2013
CANADA

DURELA

Approval Date
Mar 19, 2012
CANADA

DURELA

Approval Date
Mar 19, 2012
CANADA

DURELA

Approval Date
Mar 19, 2012
CANADA

FENOMAX

Approval Date
Nov 14, 2006
CANADA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.